Contrast-enhanced ultrasound liver reporting and data system for hepatocellular carcinoma diagnosis

Abstract

Contrast-enhanced ultrasound (CEUS) is a powerful imaging modality for the diagnosis of focal liver lesions, including hepatocellular carcinoma (HCC). The American College of Radiology Contrast-Enhanced Ultrasound Liver Reporting and Data System (CEUS LI-RADS®) was created as a standardized reporting system to facilitate consistent and high-quality technique, interpretation, reporting, and data collection for CEUS diagnosis of HCC. This article describes the history and background of CEUS LI-RADS®, its major concepts and algorithm, and the differences between CEUS LI-RADS® and CT/MRI LI-RADS®.

Keywords

Contrast-enhanced ultrasound / LI-RADS / hepatocellular carcinoma / diagnosis

References

[1] Heimbach JK,Finn RS,Abecassis MM.AASLD guidelines for the treatment of hepatocellular carcinoma..Hepatology2018;67:358-80

[2] European Association for the Study of the LiverElectronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma..J Hepatol2018;69:182-236

[3] Marrero JA,Sirlin CB,Finn RS.Diagnosis, staging, and management of hepatocellular carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases..Hepatology2018;68:723-50

[4] Claudon M,Choi BI,Kudo M.Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver - update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS..Ultrasound Med Biol2013;39:187-210

[5] Jo PC,Burns PN,Kim TK.Integration of contrast-enhanced US into a multimodality approach to imaging of nodules in a cirrhotic liver: how i do it..Radiology2017;282:317-31

[6] Quaia E.Microbubble ultrasound contrast agents: an update..Eur Radiol2007;17:1995-2008

[7] Ophir J.Contrast agents in diagnostic ultrasound..Ultrasound Med Biol1989;15:319-33

[8] Wilson SR.An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography..AJR Am J Roentgenol2006;186:1401-12

[9] Yang HK,Jang HJ,Khalili K.Contrast-enhanced ultrasound approach to the diagnosis of focal liver lesions: the importance of washout..Ultrasonography2019;38:289-301 PMCID:PMC6769186

[10] Kim TK,Wilson SR,Piscaglia F.Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system..Clin Mol Hepatol2017;23:280-9 PMCID:PMC5760002

[11] Sugimoto K,Shiraishi J,Taira J.Assessment of arterial hypervascularity of hepatocellular carcinoma: comparison of contrast-enhanced US and gadoxetate disodium-enhanced MR imaging..Eur Radiol2012;22:1205-13

[12] Streb JW,Malhi H,Grant EG.Retrospective analysis of contrast-enhanced ultrasonography effectiveness in reducing time to diagnosis and imaging-related expenditures at a single large United States County hospital..Ultrasound Q2019;35:99-102

[13] Piscaglia F.The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations..Ultrasound Med Biol2006;32:1369-75

[14] Yusuf GT,Deganello A,Sidhu PS.Retrospective analysis of the safety and cost implications of pediatric contrast-enhanced ultrasound at a single center..AJR Am J Roentgenol2017;208:446-52

[15] Ntoulia A,Darge K.Applications of contrast-enhanced ultrasound in the pediatric abdomen..Abdom Radiol (NY)2018;43:948-59

[16] Lyshchik A,Dietrich CF,Kim TK.Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group..Abdom Radiol (NY)2018;43:861-79 PMCID:PMC5886815

[17] Claudon M,Choi BI,Kudo M.Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS..Ultrasound Med Biol2013;39:187-210

[18] Tang A,Mitchell DG,Fowler KJ.Introduction to the Liver Imaging Reporting and Data System for Hepatocellular Carcinoma..Clin Gastroenterol Hepatol2019;17:1228-38

[19] Kono Y,Cosgrove D,Jang HJ.Contrast Enhanced Ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS^®): the official version by the American College of Radiology (ACR)..Ultraschall Med2017;38:85-6

[20] Omata M,Kokudo N,Lee JM.Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update..Hepatol Int2017;11:317-70 PMCID:PMC5491694

[21] Kudo M,Izumi N,Kadoya M.JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan..Liver Cancer2014;3:458-68 PMCID:PMC4531423

[22] Korean Liver Cancer Study G, National Cancer Center K2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma..Korean J Radiol2015;16:465-522 PMCID:PMC4435981

[23] Burak KW.Hepatocellular carcinoma: consensus, controversies and future directions. A report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma Meeting..Can J Gastroenterol Hepatol2015;29:178-84 PMCID:PMC4444026

[24] Bolondi L,Colombo M.Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma..Dig Liver Dis2013;45:712-23

[25] Bruix J.Management of hepatocellular carcinoma: an update..Hepatology2011;53:1020-2 PMCID:PMC3084991

[26] EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma..J Hepatol2012;56:908-43

[27] Vilana R,Bianchi L,Rimola J.Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound..Hepatology2010;51:2020-9

[28] Han J,Han F,Yan C.The degree of contrast washout on contrast-enhanced ultrasound in distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma..Ultrasound Med Biol2015;41:3088-95

[29] Li R,Ma KS,Tang CL.Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis..PLoS One2014;9:e98612 PMCID:PMC4038593

[30] Wildner D,Greis C,Neurath MF.CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial..Ultraschall Med2015;36:132-9

[31] Danila M,Popescu A.Portal vein thrombosis in liver cirrhosis - the added value of contrast enhanced ultrasonography..Med Ultrason2016;18:218-33

[32] Chen J,Zhang C,Huang P.Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis..Eur Radiol2020;30:2871-80 PMCID:PMC7160216

[33] Tublin ME,Baron RL.Benign and malignant portal vein thrombosis: differentiation by CT characteristics..AJR Am J Roentgenol1997;168:719-23

[34] Sandrasegaran K,Nutakki K,Bodanapally U.Usefulness of conventional MRI sequences and diffusion-weighted imaging in differentiating malignant from benign portal vein thrombus in cirrhotic patients..AJR Am J Roentgenol2013;201:1211-9

[35] Burrowes DP,Harris AC,Wilson SR.Contrast-enhanced US approach to the diagnosis of focal liver masses..Radiographics2017;37:1388-400

[36] Burrowes DP,Medellin A.Update: contrast-enhanced US approach to the diagnosis of focal liver masses..Radiographics2020;40:E16-20

[37] Dietrich CF,Caraiani C.Contrast enhanced ultrasound (CEUS) imaging of solid benign focal liver lesions..Expert Rev Gastroenterol Hepatol2018;12:479-89

[38] Dietrich CF.Contrast-enhanced ultrasound of benign focal liver lesions..Ultraschall Med2019;40:12-29

[39] Kim TK,Jang HJ.Imaging findings of mimickers of hepatocellular carcinoma..Clin Mol Hepatol2015;21:326-43 PMCID:PMC4712159

[40] Lanka B,Kim TK,Wilson SR.Impact of contrast-enhanced ultrasonography in a tertiary clinical practice..J Ultrasound Med2007;26:1703-14

[41] Hu J,Burak KW.Resolution of indeterminate MRI with CEUS in patients at high risk for hepatocellular carcinoma..Abdom Radiol (NY)2020;45:123-33

[42] Kono Y,Fetzer DT,Rodgers SK.Time to clarify common misconceptions about the liver imaging reporting and data system for contrast-enhanced US..Radiology2020;295:245-7

[43] Terzi E,Pompili M,Cabibbo G.Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules..J Hepatol2018;68:485-92

[44] Zheng W,Zou XB,Han F.Evaluation of contrast-enhanced US LI-RADS version 2017: application on 2020 liver nodules in patients with hepatitis B infection..Radiology2020;294:299-307

[45] Huang JY,Lu Q,Lin L.Diagnostic accuracy of CEUS LI-RADS for the characterization of liver nodules 20 mm or smaller in patients at risk for hepatocellular carcinoma..Radiology2020;294:329-39

[46] Wang JY,Xu JW,Chu L.Usefulness of the contrast-enhanced ultrasound liver imaging reporting and data system in diagnosing focal liver lesions by inexperienced radiologists..J Ultrasound Med2020;

[47] Schellhaas B,Strobel D,Kielisch C.Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS..Eur Radiol2018;28:4254-64